erythrosine has been researched along with masitinib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chapuis, T; Fink-Gremmels, J; Schrickx, JA; Teske, E; Zandvliet, M | 1 |
1 other study(ies) available for erythrosine and masitinib
Article | Year |
---|---|
Masitinib reverses doxorubicin resistance in canine lymphoid cells by inhibiting the function of P-glycoprotein.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Cell Line, Tumor; Dogs; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Fluoresceins; Gene Expression Regulation; Piperidines; Protein Kinase Inhibitors; Pyridines; Rhodamine 123; Succinimides; Thiazoles | 2013 |